Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B—lineage acute lymphoblastic leukemia. A pediatric oncology group pilot study
暂无分享,去创建一个
J. Shuster | B. Camitta | B. Leventhal | D. Mahoney | B. Kamen | D. Ganick | S. Lauer | C. Steuber | Curt J. Civin